TERT-BUTYL ((3-AMINOOXETAN-3-YL)METHYL)CARBAMATE, 95.0%, 100mg

3-Chloro-4-fluorophenylacetylene, 1g

3,4-(Ethylenedioxy)benzoic acid, 98.0%, 1g

Ethyl 4-chloro-2-fluoro-3-methoxybenzoate, 95%, 10g

1-{[3-chloro-4-(trifluoromethoxy)phenyl]methyl}-1,4-diazepane, 95.0%, 1g

ROTIPHORESE®NF-Acrylamide/Bis-solution 30 (29,1), 250 ml, glass

DL-Lactide>98.0%(T)100g

1-tert-Butyl 2-methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1,2-dicarboxylate, 95.0%, 100mg

(2-Hydroxy-4-(trifluoromethyl)phenyl)boronic acid, 95.0%, 100g

1-Bromo-2-butanone (stabilised with calcium carbonate), 80.0%, 5g

ETHYL 5-METHYL-1,3,4-THIADIAZOLE-2-CARBOXYLATE, 95.0%, 5g

Ethyl 1,2,4-thiadiazole-5-carboxylate, 95.0%, 250mg

3-Hydroxy-2,2,4-trimethylpentyl Isobutyrate (contains ca. 40% 2,2,4-Trimethyl-1,3-pentanediol 3-Monoisobutyrate)>60.0%(GC)500mL